A fragment-based exploration of diverse MMP-9 inhibitors through classification-dependent structural assessment
Copyright © 2023 Elsevier Inc. All rights reserved..
Matrix metalloproteinases (MMPs) are belonging to the Zn2+-dependent metalloenzymes. These can degenerate the extracellular matrix (ECM) that is entailed with various biological processes. Among the MMP family members, MMP-9 is associated with several pathophysiological circumstances. Apart from wound healing, remodeling of bone, inflammatory mechanisms, and rheumatoid arthritis, MMP-9 has also significant roles in tumor invasion and metastasis. Therefore, MMP-9 has been in the spotlight of anticancer drug discovery programs for more than a decade. In this present study, classification-based QSAR techniques along with fragment-based data mining have been carried out on divergent MMP-9 inhibitors to point out the important structural attributes. This current study may be able to elucidate the importance of several pivotal molecular fragments such as sulfonamide, hydroxamate, i-butyl, and ethoxy functions for imparting potential MMP-9 inhibition. These observations are in correlation with the ligand-bound co-crystal structures of MMP-9. Therefore, these findings are beneficial for the design and discovery of effective MMP-9 inhibitors in the future.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:126 |
---|---|
Enthalten in: |
Journal of molecular graphics & modelling - 126(2024) vom: 01. Jan., Seite 108671 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Baidya, Sandip Kumar [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 27.11.2023 Date Revised 17.04.2024 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.jmgm.2023.108671 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM364685174 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM364685174 | ||
003 | DE-627 | ||
005 | 20240417232251.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.jmgm.2023.108671 |2 doi | |
028 | 5 | 2 | |a pubmed24n1378.xml |
035 | |a (DE-627)NLM364685174 | ||
035 | |a (NLM)37976979 | ||
035 | |a (PII)S1093-3263(23)00269-3 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Baidya, Sandip Kumar |e verfasserin |4 aut | |
245 | 1 | 2 | |a A fragment-based exploration of diverse MMP-9 inhibitors through classification-dependent structural assessment |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 27.11.2023 | ||
500 | |a Date Revised 17.04.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2023 Elsevier Inc. All rights reserved. | ||
520 | |a Matrix metalloproteinases (MMPs) are belonging to the Zn2+-dependent metalloenzymes. These can degenerate the extracellular matrix (ECM) that is entailed with various biological processes. Among the MMP family members, MMP-9 is associated with several pathophysiological circumstances. Apart from wound healing, remodeling of bone, inflammatory mechanisms, and rheumatoid arthritis, MMP-9 has also significant roles in tumor invasion and metastasis. Therefore, MMP-9 has been in the spotlight of anticancer drug discovery programs for more than a decade. In this present study, classification-based QSAR techniques along with fragment-based data mining have been carried out on divergent MMP-9 inhibitors to point out the important structural attributes. This current study may be able to elucidate the importance of several pivotal molecular fragments such as sulfonamide, hydroxamate, i-butyl, and ethoxy functions for imparting potential MMP-9 inhibition. These observations are in correlation with the ligand-bound co-crystal structures of MMP-9. Therefore, these findings are beneficial for the design and discovery of effective MMP-9 inhibitors in the future | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a Bayesian classification | |
650 | 4 | |a Binding affinity | |
650 | 4 | |a LDA | |
650 | 4 | |a MMP-9 | |
650 | 4 | |a Recursive partitioning | |
650 | 4 | |a SARpy | |
650 | 7 | |a Matrix Metalloproteinase 9 |2 NLM | |
650 | 7 | |a EC 3.4.24.35 |2 NLM | |
650 | 7 | |a Matrix Metalloproteinase Inhibitors |2 NLM | |
650 | 7 | |a Sulfonamides |2 NLM | |
700 | 1 | |a Banerjee, Suvankar |e verfasserin |4 aut | |
700 | 1 | |a Ghosh, Balaram |e verfasserin |4 aut | |
700 | 1 | |a Jha, Tarun |e verfasserin |4 aut | |
700 | 1 | |a Adhikari, Nilanjan |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Journal of molecular graphics & modelling |d 1998 |g 126(2024) vom: 01. Jan., Seite 108671 |w (DE-627)NLM092915620 |x 1873-4243 |7 nnns |
773 | 1 | 8 | |g volume:126 |g year:2024 |g day:01 |g month:01 |g pages:108671 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.jmgm.2023.108671 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 126 |j 2024 |b 01 |c 01 |h 108671 |